An increasing awareness of the importance of the role different bacterial ecosystems play with regards to human and animal health has led to a surge in research, publications and companies coming out of the microbiome and probiotic space. As changes in our lifestyle and the growth of multi-drug resistant bacterial strains have also increased the need for better solutions and management of chronic and life-threatening illnesses, microbiome and probiotic research is one of the most scientifically important and potentially lucrative avenues to be exploring. There is mounting evidence that selected probiotic strains can confer health benefits especially in digestive diseases and pediatric health. Further research into mechanisms of action for particular strains; large-cohort clinical trials; and compliance with good manufacturing practice and standards will result in the next generation of probiotic products to ultimately advance patient care and animal health.
The co-located congress will attract over 275 attendees, and expand on our highly popular US, European and Asian microbiome forums as well as this year’s inaugural Probiotics Congress in Malaysia to explore the development of the next generation of probiotics, prebiotics and functional foods and their impact of human health. The congress will showcase a series of interactive presentations with leading academics and industry experts, panel discussions and an exhibition area allowing solution providers to highlight their products and services.